
    
      The patients will be included the 1. or 2. day after surgery. All TKA patients will be
      screened. Those reporting VAS > 60 during active 45 degrees knee flexion will be asked to
      participate.

      Included patients will receive 2xACB (singleshot) first placebo (30ml saline) and then
      ropivacaine (30ml ropivacaine 7,5mg/ml) or the other way around (randomized). There will be
      45 minutes between the two blockades. The blockades will be ultrasound guided.
    
  